SPONSOR
Université de Sherbrooke
Total Trials
7
Recruiting
7
Phases
Phase 2, Phase 3
Conditions studied: NeuromodulationLaceration - InjuryInfectionMyotonic Dystrophy Type 1Urinary IncontinenceTriple-Negative Breast CancerCardiovascular DiseasesFrailtyColorectal CancerBreast Cancer
Université de Sherbrooke is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Neuromodulation, Laceration - Injury, Infection, Myotonic Dystrophy Type 1.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Université de Sherbrooke
How many clinical trials has Université de Sherbrooke sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Université de Sherbrooke, of which 7 are actively recruiting participants. These trials cover conditions including Neuromodulation, Laceration - Injury, Infection. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Université de Sherbrooke research focus on?
Université de Sherbrooke clinical trials span Neuromodulation, Laceration - Injury, Infection, Myotonic Dystrophy Type 1, Urinary Incontinence, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Université de Sherbrooke clinical trial?
To participate in a Université de Sherbrooke trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Université de Sherbrooke trials with current recruitment status updated daily.
Clinical Trials by Université de Sherbrooke
NCT06464445
Recruiting
Optimization of ITBS for Depression
Neuromodulation
NCT02976480
Recruiting
The Irrigation or No Irrigation in Simple Lacerations Trials
Laceration - Injury
NCT06316778
Recruiting
Pelvic Floor Muscle Training for Women with Myotonic Dystrophy
Myotonic Dystrophy Type 1
NCT07104266 Phase 2
Recruiting
Triple Negative Breast Cancer and Celecoxib. Pilot Study
Triple-Negative Breast Cancer
NCT06810661
Recruiting
Managing Frailty Through Mobilization in Males and Female Inpatients With Cardiovascular Disease
Cardiovascular Diseases
NCT06911970
Recruiting
Impact of Aerobic Exercise on the Anticancer Immune Response in Patients Receiving Cancer Treatment
Colorectal Cancer
NCT07309614 Phase 3
Recruiting
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
Asthma Control
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology